Medical News

RSS

Practice Fusion patient survey: Doctors are making use of EHR systems

The health IT landscape has changed fundamentally in the first year since the American Recovery and Reinvestment Act was signed into law. American patients are seeing their doctors make the switch to Electronic Health Record (EHR) systems, according to a survey conducted by GfK Roper for Practice Fusion, the fastest growing EHR community in the US.

10 Feb 2010

STDUniversity.org launches interactive, personalized STD test recommendation

STDUniversity.org is the first website to provide an interactive, personalized STD test recommendation developed by academic and medical experts. This expert-based tool incorporates screening guidelines from the Centers for Disease Control and Prevention (CDC), U.S. Agency for Healthcare Research and Quality (AHRQ), and the U.S. Preventive Service Task Force (USPSTF).

10 Feb 2010

New OKI Semiconductor module offers improved automated fingerprint identification and access control

The new OKI Semiconductor MK67Q5250 fingerprint matching module is designed to speed implementation of automated fingerprint identification and access control in applications ranging from locks and garage door openers to portable devices, computer workstations and POS terminals.

10 Feb 2010

MDS to divest remaining MDS Pharma Services Early Stage business for $45M

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed agreements to divest its remaining MDS Pharma Services Early Stage business, which provides Discovery through Phase IIa clinical trial services to biotechnology and pharmaceutical companies, for $45 million and certain minority equity interests.

10 Feb 2010

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".

10 Feb 2010

Update on SOKO Fitness & Spa Group's recently broadened geographic expansion strategy

SOKO Fitness & Spa Group, Inc. ("SOKO" or the "Company"), an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today provided an update on its recently broadened geographic expansion strategy.

10 Feb 2010

Goodwin Biotechnology, Macrocyclics announce collaboration on Chelation and Bioconjugation

Goodwin Biotechnology Inc., a full service Contract Biomanufacturing Company and Macrocyclics, Inc., a manufacturer of customized chelating agents, jointly announced today their collaborative agreement on Chelation and Bioconjugation. The collaboration will strengthen joint customer projects in Nuclear Medicine involving Chelation, Bioconjugation and GMP manufacturing.

10 Feb 2010

CMA launches Physician Assistant Toolkit

The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).

10 Feb 2010

Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products

Avrio Biopharmaceuticals, LLC, a wholly-owned subsidiary of Irvine Pharmaceutical Services, Inc., received approval to manufacture and ship pharmaceutical products by the California Department of Public Health, Food and Drug Branch (Cal FDB), completing the organization's portfolio of product development services in support of its pharmaceutical, biopharmaceutical, and medical device clients.

10 Feb 2010

IndicatorEDG survey reveals Americans find less chance of achieving personal dreams

Luth Research's IndicatorEDG survey finds Americans are less likely to feel their dreams are attainable. Back in the third quarter of 2006, 62% of Americans said they had an excellent, very good or good chance of achieving their personal dreams.

10 Feb 2010

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel glycine site functional partial agonist (GFPA) NMDA receptor modulators, today reported positive top-line results from its Phase I clinical trial of lead compound GLYX-13.

10 Feb 2010

Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International

Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.

10 Feb 2010

UnitedHealth Group pays annual dividend to shareholders; renews Share Repurchase Program

UnitedHealth Group (NYSE:UNH) announced today that its Board of Directors, at its regular meeting on February 9, 2010, authorized payment of an annual dividend to shareholders for 2010.

10 Feb 2010

Kinexus Bioinformatics announces the commercial release of Protein Kinase Microarray

Kinexus Bioinformatics Corporation announced the commercial release of its novel Protein Kinase Microarray with 200 recombinant human protein kinases for screening. The microarray has wide utility including applications for drug target counter screening, to identify novel kinase substrates, establish kinase antibody specificities, and for the discovery and testing of protein kinase-protein and protein kinase-compound interactions.

10 Feb 2010

DMC recommends JV to continue enrolling patients in Phase III clinical trial of StemEx

The Gamida Cell-Teva Joint Venture (JV) announced today that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.

10 Feb 2010

NeuroMetrix announces 2009 fourth quarter financial results

NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended December 31, 2009.

10 Feb 2010

Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drug

Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into a collaboration and license agreement with Alexza Pharmaceuticals, Inc.

10 Feb 2010

BioClinica reports financial results for quarter and year ended December 31, 2009

BioClinica™, Inc., a global provider of clinical trial services, today announced its financial results for the quarter and year ended December 31, 2009. The operating results of Phoenix Data Systems (“PDS”) are included in the financial results following the acquisition of PDS that was completed March 24, 2008.

From Clario 10 Feb 2010

Second-quarter fiscal 2010 results announced by Bioniche Life Sciences

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 second quarter, ended December 31, 2009.

10 Feb 2010

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.

10 Feb 2010

Medical News

Practice Fusion patient survey: Doctors are making use of EHR systems

STDUniversity.org launches interactive, personalized STD test recommendation

New OKI Semiconductor module offers improved automated fingerprint identification and access control

MDS to divest remaining MDS Pharma Services Early Stage business for $45M

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Update on SOKO Fitness & Spa Group's recently broadened geographic expansion strategy

Goodwin Biotechnology, Macrocyclics announce collaboration on Chelation and Bioconjugation

CMA launches Physician Assistant Toolkit

Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products

IndicatorEDG survey reveals Americans find less chance of achieving personal dreams

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International

UnitedHealth Group pays annual dividend to shareholders; renews Share Repurchase Program

Kinexus Bioinformatics announces the commercial release of Protein Kinase Microarray

DMC recommends JV to continue enrolling patients in Phase III clinical trial of StemEx

NeuroMetrix announces 2009 fourth quarter financial results

Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drug

BioClinica reports financial results for quarter and year ended December 31, 2009

Second-quarter fiscal 2010 results announced by Bioniche Life Sciences

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News